Gilead Sciences Revenue, Growth & Competitor Profile

DBA GILEAD

Company Profile & Annual Report for Gilead Sciences

Access the complete profile.

Gilead Sciences Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services
Address	333 Lakeside Drive Foster City, CA 94404

Gilead Sciences's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Gilead Sciences's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Gilead Sciences is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Gilead Sciences is a publicly traded company on NMS using the ticker symbol GILD. Detailed information on company financials and operating reports can be found here: NMS: GILD

Gilead Sciences Annual Revenue and Growth Rate

Gilead Sciences	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	Over $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Gilead Sciences's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Gilead Sciences is developing and marketing. Gilead Sciences doesn't have any recent trademark applications, indicating Gilead Sciences is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ZERO HOUR Downloadable podcasts in the field of healthcare, medicine, public health, infectious diseases, and medical conditions	03/16/2023
HELPING TO BRING MORE LIFE TO PEOPLE WITH CANCER Promoting public awareness in the field of oncology, namely, medical and scientific research, treatment, diagnosis and patient and family services	02/07/2023
CREATING POSSIBLE FUND charitable services, namely, providing financial grants to individuals, organizations and programs in support of improving health, well-being and social justice; philanthropic services concerning monetary donations	09/14/2022

See all trademarks and details in the Full Report.

Market Share of Gilead Sciences's Largest Competitors

A competitive analysis shows these companies are in the same general field as Gilead Sciences, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Gilead Sciences. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GILEAD SCIENCES	Foster City, CA	100
SCICLONE PHARMACEUTICALS	San Mateo, CA	1
DOMPE U.S.	San Mateo, CA	1
FORTY SEVEN	San Mateo, CA	0
REVIR THERAPEUTICS	Foster City, CA	0
MICURX PHARMACEUTICALS	Foster City, CA	0

Future Competition: Gilead Sciences's Fastest Growing Competitors

These companies are in the same general field as Gilead Sciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)